-
-
-
-
-
-
-
Citizens JMP Reiterates Market Perform Rating on Sutro Biopharma (STRO)
-
-
-
-
-
-
-
Oppenheimer Downgrades Sutro Biopharma (STRO) to Perform
-
-
-
-
-
-
-
JMP Securities Biotechnology Overview
-
-
-
-
-
-
-
Sutro Biopharma Inc. (STRO) Announces Initiation of REFRαME-L1 Phase 2 Trial with Luvelta for Patients with Non-Small Cell Lung Cancer
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

